Literature DB >> 2574075

Role of alpha 1-adrenoceptor activity in progression of cardiac hypertrophy in guinea pig hearts with pressure overload.

J Tamai1, M Hori, T Kagiya, K Iwakura, K Iwai, A Kitabatake, Y Watanabe, H Yoshida, M Inoue, T Kamada.   

Abstract

To elucidate the role of alpha 1- and beta-adrenergic activities in pressure overload hypertrophy, changes of alpha 1- and beta-adrenoceptors were measured by radioligand binding assay, and the preventive effects of alpha 1- and beta-adrenoceptor blockade on cardiac hypertrophy were assessed in guinea pigs after aortic banding. Five days after banding, dry weight of left ventricle had not increased, though wet weight increased due to marked intercellular oedema. In this period, the maximum binding capacity of [3H] prazosin increased to 31.1 (SEM 2.2) fmol.mg-1 from (sham operation) 17.0(2.1) fmol.mg protein-1, p less than 0.01, whereas the maximum binding capacity of [3H]dihydroalprenolol did not increase: 143(16) fmol.mg-1 (banded) v 153(13) fmol.mg-1 (sham). Three weeks after aortic banding, the maximum binding capacity of both ligands increased to 45.6(5.5) fmol.mg-1 and 232(21) fmol.mg-1, respectively, accompanied by a significant increase in left ventricular dry weight, from 0.46(0.02) mg.g-1 (sham) to 0.62(0.08) mg.g-1 (banded), p less than 0.01. Continuous subcutaneous administration of the alpha 1-blocker bunazosin (0.1 mg.kg-1.d-1) significantly attenuated the increase in left ventricular dry weight whereas the beta-blocker propranolol (5 mg.kg-1.d-1) did not: 0.55(0.03) v 0.66(0.04) mg.g-1 respectively, after 3 weeks. These results show that pressure overload elicited an increase in myocardial alpha 1-adrenoceptors before the onset of cardiac hypertrophy, and that an alpha 1-blocker could prevent the development of hypertrophy in the pressure overloaded heart.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2574075     DOI: 10.1093/cvr/23.4.315

Source DB:  PubMed          Journal:  Cardiovasc Res        ISSN: 0008-6363            Impact factor:   10.787


  3 in total

1.  Effect of angiotensin converting enzyme inhibitor on regression in cardiac hypertrophy.

Authors:  N Makino; H Matsui; K Masutomo; T Hata; T Yanaga
Journal:  Mol Cell Biochem       Date:  1993-02-17       Impact factor: 3.396

Review 2.  The 'athletic heart syndrome'. A critical review.

Authors:  K P George; L A Wolfe; G W Burggraf
Journal:  Sports Med       Date:  1991-05       Impact factor: 11.136

3.  Myocyte apoptosis occurs early during the development of pressure-overload hypertrophy in infant myocardium.

Authors:  Yeong-Hoon Choi; Douglas B Cowan; Adrian M Moran; Steven D Colan; Christof Stamm; Koh Takeuchi; Ingeborg Friehs; Pedro J del Nido; Francis X McGowan
Journal:  J Thorac Cardiovasc Surg       Date:  2009-03-17       Impact factor: 5.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.